Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Schutzer

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Ageing Research Reviews|February 28, 2003
Age-related changes in vascular adrenergic signaling: clinical and mechanistic implicationsWilliam E Schutzer, Scott L Mader
International Journal of Hypertension|October 1, 2011
Biochemical and molecular aspects of vascular adrenergic regulation of blood pressure in the elderlyWilliam E Schutzer, Scott L Mader
American Journal of Physiology. Heart and Circulatory Physiology|January 1, 2005
Decline in caveolin-1 expression and scaffolding of G protein receptor kinase-2 with age in Fischer 344 aortic vascular smooth muscleWilliam E Schutzer, John F Reed, Scott L Mader
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 9, 2006
Effect of age on vascular beta2-adrenergic receptor desensitization is not mediated by the receptor coupling to Galphai proteinsWilliam E Schutzer, Hong Xue, John F Reed, et al.
Drug and Alcohol Dependence|September 7, 2021
Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatmentsNicholas B Miner, William E Schutzer, Yalda Zarnegarnia, et al.
In Vitro Cellular & Developmental Biology. Animal|June 10, 2011
Characterization of clonal vascular smooth muscle cell lines derived from young and old Fischer 344 ratsWilliam E Schutzer, Douglas R Beard, John F Reed, et al.
Molecular Pharmacology|August 21, 2025
Trace amine-associated receptor 1 agonists differentially regulate dopamine transporter functionJulia K Huey, Xiao Shi, William E Schutzer, et al.
Vascular Pharmacology|September 29, 2011
Age-related β-adrenergic receptor-mediated vasorelaxation is changed by altering G protein receptor kinase 2 expressionWilliam E Schutzer, Hong Xue, John Reed, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Combining the alpha-2 adrenergic agonist clonidine with naloxone rescues fentanyl-induced physiologic dysfunction and increases survivalAlyssa Rivera, William E Schutzer, Alex Sonneborn, et al.
American Journal of Physiology. Renal Physiology|December 14, 2011
2-Hydroxyestradiol slows progression of experimental polycystic kidney diseaseSharon Anderson, Terry T Oyama, Jessie N Lindsley, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Ageing Research Reviews|February 28, 2003
Age-related changes in vascular adrenergic signaling: clinical and mechanistic implicationsWilliam E Schutzer, Scott L Mader
International Journal of Hypertension|October 1, 2011
Biochemical and molecular aspects of vascular adrenergic regulation of blood pressure in the elderlyWilliam E Schutzer, Scott L Mader
American Journal of Physiology. Heart and Circulatory Physiology|January 1, 2005
Decline in caveolin-1 expression and scaffolding of G protein receptor kinase-2 with age in Fischer 344 aortic vascular smooth muscleWilliam E Schutzer, John F Reed, Scott L Mader
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 9, 2006
Effect of age on vascular beta2-adrenergic receptor desensitization is not mediated by the receptor coupling to Galphai proteinsWilliam E Schutzer, Hong Xue, John F Reed, et al.
Drug and Alcohol Dependence|September 7, 2021
Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatmentsNicholas B Miner, William E Schutzer, Yalda Zarnegarnia, et al.
In Vitro Cellular & Developmental Biology. Animal|June 10, 2011
Characterization of clonal vascular smooth muscle cell lines derived from young and old Fischer 344 ratsWilliam E Schutzer, Douglas R Beard, John F Reed, et al.
Molecular Pharmacology|August 21, 2025
Trace amine-associated receptor 1 agonists differentially regulate dopamine transporter functionJulia K Huey, Xiao Shi, William E Schutzer, et al.
Vascular Pharmacology|September 29, 2011
Age-related β-adrenergic receptor-mediated vasorelaxation is changed by altering G protein receptor kinase 2 expressionWilliam E Schutzer, Hong Xue, John Reed, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Combining the alpha-2 adrenergic agonist clonidine with naloxone rescues fentanyl-induced physiologic dysfunction and increases survivalAlyssa Rivera, William E Schutzer, Alex Sonneborn, et al.
American Journal of Physiology. Renal Physiology|December 14, 2011
2-Hydroxyestradiol slows progression of experimental polycystic kidney diseaseSharon Anderson, Terry T Oyama, Jessie N Lindsley, et al.
Pageof 2